Endothelial Nitric Oxide Synthase −786T>C, but Not 894G>T and 4a4b, Polymorphism Influences Plasma Homocysteine Concentrations in Persons with Normal Vitamin Status
Open Access
- 1 July 2005
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 51 (7) , 1159-1164
Abstract
Background: Nitric oxide (NO) plays a relevant role in various events during atherogenesis. In vitro data suggest that NO may modulate homocysteine (Hcy) concentrations. The aim of this study was to investigate the role of endothelial nitric oxide synthase (eNOS) −786T>C, 894G>T, and 4a4b polymorphisms in influencing Hcy concentrations. Methods: Blood samples were obtained from 1287 unrelated persons. Plasma Hcy was measured by fluorescence polarization immunoassay, folate and vitamin B12 by RIA, vitamin B6 by HPLC, and eNOS and methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms by PCR with restriction fragment length polymorphism analysis. Results:MTHFR 677C>T polymorphism significantly influenced Hcy concentrations after adjustment for all confounding variables (P C polymorphism, but not 894G>T and 4a4b, was significantly associated with the risk of having Hcy in the third tertile [>13.4 μmol/L; odds ratio (OR) = 1.2; 95% confidence interval (CI), 1.02–1.5; P = 0.03]. After adjustment for all variables known to influence Hcy, the −786T>C polymorphism still influenced Hcy concentrations (OR = 1.9; 95% CI, 1.1–3.2; P = 0.01). By analyzing the influence of eNOS polymorphisms on plasma Hcy concentrations according to vitamin concentrations (folate, vitamin B6, and vitamin B12), age, and smoking habits, we found a significant association between the eNOS −786T>C polymorphism and Hcy in nonsmokers, in persons with normal vitamin status, and in persons Conclusion: The eNOS −786T>C polymorphism, but not 894G>T and 4a4b, influences plasma Hcy concentrations mildly but significantly and independently.Keywords
This publication has 30 references indexed in Scilit:
- The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxideJournal Of Hypertension, 2002
- Homocysteine and cardiovascular disease:The American Journal of Medicine, 2002
- Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population‐based cohortJournal of Internal Medicine, 2002
- Nitric Oxide Inhibits Methionine Synthase Activity in Vivo and Disrupts Carbon Flow through the Folate PathwayJournal of Biological Chemistry, 2001
- Polymorphisms in endothelial nitric oxide synthase and atherogenesisAtherosclerosis, 2001
- Nitric Oxide: Nature's Naturally Occurring Leukocyte InhibitorCirculation, 1997
- The L-Arginine-Nitric Oxide PathwayNew England Journal of Medicine, 1993
- Inhibition of low‐density lipoprotein oxidation by nitric oxide Potential role in atherogenesisFEBS Letters, 1993
- Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.Journal of Clinical Investigation, 1989
- ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUMThe Lancet, 1987